Production (Stage)
ALX Oncology Holdings Inc.
ALXO
$0.4637
-$0.0152-3.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.02% | 16.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.94% | -6.00% | |||
| Operating Income | -3.94% | 6.00% | |||
| Income Before Tax | -5.46% | 5.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.46% | 5.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.46% | 5.03% | |||
| EBIT | -3.94% | 6.00% | |||
| EBITDA | -3.98% | 6.02% | |||
| EPS Basic | -4.36% | 5.22% | |||
| Normalized Basic EPS | -4.35% | 5.22% | |||
| EPS Diluted | -4.36% | 5.22% | |||
| Normalized Diluted EPS | -4.35% | 5.22% | |||
| Average Basic Shares Outstanding | 1.05% | 0.21% | |||
| Average Diluted Shares Outstanding | 1.05% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||